-
Is it possible to bottle up all the health benefits of exercise into a pill?
22 Oct 2021 20:35 GMT
We all know exercise is good for us — it's why we keep persevering when it starts to feel really hard.
Moving your body is important for heart health, wellbeing, and maintaining a healthy weight.
But exercise also has benefits for your brain, and …
-
Athira Pharma Announces Completion of Enrollment in Phase 2 ACT-AD Trial Evaluating ATH-1017 for Mild-to-Moderate Alzheimer's Disease
22 Oct 2021 14:23 GMT
(MENAFN- GlobeNewsWire - Nasdaq) -Topline data targeted for 1H22- BOTHELL, Wash., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore …
-
Cognitive and Memory Enhancer Drugs Market 2021: Explore Key Factors that Will Boost the Global Market by 2030
22 Oct 2021 11:18 GMT
PORTLAND, OR, UNITED STATES, October 22, 2021 /EINPresswire.com/ -- Most of the college students, professionals, and entrepreneurs are using smart drugs to maximize their mental capabilities. For instance, Piracetam improves memory in seniors …
-
Parkinson's Disease Treatment Market 2021 Current and Future Trend Scenario Explored In New Latest Research Report By 2030
21 Oct 2021 05:46 GMT
The MarketWatch News Department was not involved in the creation of this content.
Oct 21, 2021 (AmericaNewsHour) --
In a recent published report, Kenneth Research has updated the market report for Parkinson's Disease Treatment Market for 2021 till 2030 …
-
Researchers develop a new method to remove old cells from tissues to slow down aging
21 Oct 2021 02:45 GMT
No one knows why some people age worse than others and develop diseases -such as Alzheimer's, fibrosis, type 2 diabetes or some types of cancer- associated with this aging process. One explanation for this could be the degree of efficiency of each …
-
Help with Parkinson's Disease symptoms
20 Oct 2021 19:01 GMT
DEAR DR. ROACH: Is acupuncture a possible therapy to relieve back pain and stiffness associated with Parkinson’s disease? – R.G.
ANSWER: There have been many trials that show acupuncture is superior to no treatment for various symptoms of Parkinson’s …
-
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
20 Oct 2021 01:53 GMT
MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021
- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire…
-
Parkinson's treatment holds hope for St. Pete sculptor
14 Oct 2021 15:24 GMT
ST. PETERSBURG, Fla. — Don Gialanella's morning starts like most, with some breakfast and a little hope.
"Eggs?" asks Hope Crosson.
"That sounds good," replies Don. With a cup of coffee in his hand, he adds, "Get a little …
-
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products
19 Oct 2021 13:22 GMT
(MENAFN- GlobeNewsWire - Nasdaq)
Leading U.S.-based CDMO to manufacture PharmaTher's proprietary ketamine products for FDA Phase 3 clinical studies and global commercialization. Expected FDA clinical and commercial supply in H2-2022. Unlocking …
-
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
18 Oct 2021 12:16 GMT
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.
Moderna, Inc. (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) posted gains for …
About
© 1995-2021